Rooting Out Recurrent Breast CancerMain Category: Breast Cancer
Article Date: 12 Feb 2013 - 0:00 PST
Rooting Out Recurrent Breast Cancer
|Patient / Public:|
Due to chemotherapy resistance and a high rate of relapse, triple negative cancers are among the most difficult breast cancers to treat.
In this issue of the Journal of Clinical Investigation, researchers led by Carlos Arteaga at Vanderbilt University identified a protein, TGF-β, that is highly expressed in triple negative breast cancer cells after chemotherapy.
In a mouse model of breast cancer, TGF-β both diverted cells down a path to becoming cancerous and allowed for cancer to come back after treatment. Importantly, loss of TGF-β prevented tumor recurrence in mice. These studies identify a mechanism by which cancer cells elude standard chemotherapy and provide a rationale for testing the therapeutic potential of agents that block TGF-β.
TITLE: TGFβ inhibition enhances chemotherapy action against triple negative breast cancer
View this article at: http://www.jci.org/articles/view/65416?key=201b874c7a54cc627c43
Visit our breast cancer section for the latest news on this subject.
18 May. 2013. <http://www.medicalnewstoday.com/releases/256146.php>
Please note: If no author information is provided, the source is cited instead.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.